229 related articles for article (PubMed ID: 18320096)
1. First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
Cardiovasc J Afr; 2008; 19(1):60. PubMed ID: 18320096
[No Abstract] [Full Text] [Related]
2. [The Saturn study].
Fineschi M; Gaspardone A
G Ital Cardiol (Rome); 2012; 13(7-8):469-73. PubMed ID: 22781373
[No Abstract] [Full Text] [Related]
3. Women are from SATURN and men are from an ASTEROID: deciphering the REVERSAL of coronary atheroma.
Garcia-Garcia HM; Campos CM; Serruys PW
JACC Cardiovasc Imaging; 2014 Oct; 7(10):1023-4. PubMed ID: 25323164
[No Abstract] [Full Text] [Related]
4. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
[TBL] [Abstract][Full Text] [Related]
5. [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732408
[No Abstract] [Full Text] [Related]
6. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
[TBL] [Abstract][Full Text] [Related]
7. The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients.
Koksal M; Eren MA; Turan MN; Sabuncu T
Eur J Intern Med; 2011 Jun; 22(3):249-53. PubMed ID: 21570643
[TBL] [Abstract][Full Text] [Related]
8. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
Ai M; Otokozawa S; Asztalos BF; Nakajima K; Stein E; Jones PH; Schaefer EJ
Am J Cardiol; 2008 Feb; 101(3):315-8. PubMed ID: 18237592
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
[TBL] [Abstract][Full Text] [Related]
10. High coronary plaque load: a heavy burden.
de Graaf MA; Jukema JW
Eur Heart J; 2013 Nov; 34(41):3168-70. PubMed ID: 23966308
[No Abstract] [Full Text] [Related]
11. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
Einecke D
MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796
[No Abstract] [Full Text] [Related]
12. Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis.
Middleton A; Binbrek AS; Fonseca FA; Wilpshaar W; Watkins C; Strandberg TE
Curr Med Res Opin; 2006 Jun; 22(6):1181-91. PubMed ID: 16846551
[TBL] [Abstract][Full Text] [Related]
13. Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters.
Karalis IK; Bergheanu SC; Wolterbeek R; Dallinga-Thie GM; Hattori H; van Tol A; Liem AH; Wouter Jukema J
Curr Med Res Opin; 2010 Oct; 26(10):2301-13. PubMed ID: 20731529
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.
Lablanche JM; Leone A; Merkely B; Morais J; Alonso J; Santini M; Eha J; Demil N; Licour M; Tardif JC;
Arch Cardiovasc Dis; 2010 Mar; 103(3):160-9. PubMed ID: 20417447
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin-induced arrest in progression of renal disease.
Vidt DG; Cressman MD; Harris S; Pears JS; Hutchinson HG
Cardiology; 2004; 102(1):52-60. PubMed ID: 15073451
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
[TBL] [Abstract][Full Text] [Related]
17. Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
JACC Cardiovasc Imaging; 2014 Oct; 7(10):1013-22. PubMed ID: 25240453
[TBL] [Abstract][Full Text] [Related]
18. Statin wars: emphasis on potency vs event reduction and safety?
Lavie CJ; Milani RV; O'Keefe JH
Mayo Clin Proc; 2007 May; 82(5):539-42. PubMed ID: 17493417
[No Abstract] [Full Text] [Related]
19. Comparison of rosuvastatin versus atorvastatin for preventing postoperative atrial fibrillation.
Abaci O; Kocas C; Oktay V; Yildiz CE; Kilickesmez KO; Coskun U; Yildiz A; Yigit Z
Heart Surg Forum; 2013 Jun; 16(3):E158-61. PubMed ID: 23803242
[TBL] [Abstract][Full Text] [Related]
20. Extended ASCOT - lipid lowering (ASCOT-LLA) study shows positive results of atorvastatin.
Cardiovasc J Afr; 2008; 19(1):49-51. PubMed ID: 18320090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
